PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.82%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
58.31%
Gross profit growth above 1.5x 1097.HK's 9.11%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
No Data
No Data available this quarter, please select a different quarter.
17.02%
Operating income growth 1.25-1.5x 1097.HK's 12.76%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
-145.72%
Negative net income growth while 1097.HK stands at 8.09%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-144.83%
Negative EPS growth while 1097.HK is at 7.28%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-144.83%
Negative diluted EPS growth while 1097.HK is at 8.28%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-111.34%
Negative OCF growth while 1097.HK is at 656.66%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-133.64%
Negative FCF growth while 1097.HK is at 143.62%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-92.97%
Negative 10Y revenue/share CAGR while 1097.HK stands at 2.84%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
22775.59%
5Y revenue/share CAGR above 1.5x 1097.HK's 24.94%. David Dodd would look for consistent product or market expansions fueling outperformance.
2990.65%
Positive 3Y CAGR while 1097.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-222.25%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-149.48%
Negative 5Y OCF/share CAGR while 1097.HK is at 129.28%. Joel Greenblatt would question the firm’s operational model or cost structure.
-263.02%
Negative 3Y OCF/share CAGR while 1097.HK stands at 10.79%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-517.17%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-3602.95%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-13520.87%
Negative 3Y CAGR while 1097.HK is 37.92%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
210.52%
Positive 5Y equity/share CAGR while 1097.HK is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
10.06%
Positive short-term equity growth while 1097.HK is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-100.00%
Negative near-term dividend growth while 1097.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-34.15%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
356.23%
We show growth while 1097.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-27.14%
Negative asset growth while 1097.HK invests at 0.35%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-21.25%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-83.31%
We’re deleveraging while 1097.HK stands at 30.43%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
531.86%
We expand SG&A while 1097.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.